Chinese Journal of Pharmacovigilance ›› 2023, Vol. 20 ›› Issue (3): 348-352.
DOI: 10.19803/j.1672-8629.20210520

Previous Articles     Next Articles

Research progress in Yi medicine Valeriana jatamans and predictive analysis of related quality markers

CAI Yuluo1, GUO Jiahui1, Wang Xinguo1,2,3, TIAN Yilong1,2,3, WANG Meng1,2,3, NIU Liying1,2,3#, LI Junshan1,2,3,4,*   

  1. 1Hebei University of Chinese Medicine, Shijiazhuang Hebei 050091, China;
    2Hebei TCM Formula Granule Innovation Center, Shijiazhuang Hebei 050091, China;
    3Hebei TCM Quality Evaluation & Standardization Engineering Research Center, Shijiazhuang Hebei 050091, China;
    4Shineway Pharmaceutical Group Ltd., Shijiazhuang Hebei 051430, China
  • Received:2021-05-20 Online:2023-03-15 Published:2023-03-17

Abstract: The Yi medicine Valeriana jatamansi contains many chemical components, such as iridoids, volatile oils, lignans and flavonoids. According to modern pharmaceutical research, Valeriana jatamansi delivers a range of pharmacological effects, such as central inhibition, antibacterial and antiviral effects, cytotoxicity and anti-tumor effect. Based on the concept of Q-markers, this article predicted and analyzed the Q-marker components of Valeriana jatamansi in terms of specificity, traditional medicinal effects, traditional medicinal properties, and measurability of chemical constituents in the hopes of providing reference for quality control and rational use of Valeriana jatamansi.

Key words: Valeriana jatamansi, iridoids, volatile oils, pharmacological effects, quality control, quality marker

CLC Number: